Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team

Peptonic Medical

0.00 SEK

0.00 %

Less than 1K followers

PMED

Spotlight Stock Market

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data

Income statement

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Peptonic Medical

2019202020212022202320242025
Revenue4.421.331.643.637.126.914.8
growth-%382.8 %48.7 %37.9 %-14.9 %-27.6 %-45.0 %
EBITDA-21.1-27.8-46.7-30.1-34.9-52.0-13.7
EBIT-23.9-31.1-73.7-33.6-41.2-58.7-19.4
Profit before taxes-24.5-31.3-73.7-36.9-42.6-60.0-22.5
Net income-24.5-31.1-73.7-36.9-42.6-60.0-22.5
EPS-0.08-0.08-0.16-0.06-0.03-0.020.00
Dividend0.000.000.000.000.000.000.00
Dividend ratio-0.0 %-0.0 %-0.0 %-0.0 %-0.0 %-0.0 %

Profitability and return on capital

2019202020212022202320242025
EBITDA-%-477.9 %-130.5 %-147.5 %-69.0 %-94.0 %-193.2 %-92.6 %
EBIT-%-542.7 %-145.9 %-233.0 %-77.0 %-110.9 %-218.1 %-131.5 %
ROE-28.6 %-26.4 %-141.7 %-78.3 %-56.5 %-123.6 %-58.8 %
ROI-26.7 %-23.1 %-88.2 %-43.0 %-39.9 %-85.1 %-34.1 %
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.